Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.2918949292927567e-22,10.650099342809108,530.6677514162694,"['RPL32', 'RPL34', 'RPLP1', 'RPL12', 'RPL36A', 'RPL10A', 'RPL9', 'RPL7', 'RPS15', 'RPS15A', 'RPS19', 'RPS18', 'RPL35', 'RPL38', 'RPL37', 'RPS2', 'RPS11', 'RPS27A', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPL19', 'RPS9', 'RPL41', 'RPS7', 'RPL21', 'RPL35A', 'RPSA', 'RPS3A', 'RPL23A', 'RPS26', 'RPS25', 'RPS27', 'RPS29', 'RPL37A', 'RPL24', 'RPL26', 'FAU', 'RPS21', 'RPS23']",9.923905043837637e-20,0,0,41
2,Complement system WP2806,2.8564298630922265e-06,6.378347250215952,81.42558561861982,"['SELPLG', 'CD93', 'PROS1', 'F13A1', 'C5', 'FCGR3A', 'RPS19', 'ITGAX', 'SPP1', 'VSIG4', 'CALR', 'CD55', 'TLR2']",0.0006184170653594671,0,0,13
3,"GPCRs, Class A Rhodopsin-like WP455",4.373360968763275e-06,6.764285714285714,83.47114193303062,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'HRH1', 'GPR34', 'HRH2', 'GPR65', 'GPR22', 'ADRB2', 'OPRM1']",0.0006312217664914995,0,0,12
4,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.632577340085686e-05,3.434208394101442,37.85447383612084,"['NDUFA7', 'NDUFA4', 'COX4I1', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'ATP5F1E', 'ATP5MC1', 'ATP5IF1', 'UQCRQ', 'NDUFS6', 'NDUFAB1', 'UQCRFS1', 'ATP5MF']",0.0017672649706427551,0,0,20
5,Mitochondrial CIV Assembly WP4922,4.5679341533335556e-05,6.248167692758722,62.4433407166889,"['PET100', 'NDUFA4', 'SCO2', 'COX4I1', 'COX7A2', 'COX14', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C']",0.003955830976786859,0,0,10
6,Development and heterogeneity of the ILC family WP3893,0.0001709158709827888,18.654434250764528,161.81488850457907,"['NFIL3', 'IL15', 'ZBTB16', 'ID2', 'RORA']",0.012334428689257925,0,0,5
7,"GPCRs, Other WP117",0.0005266912045493263,6.539312308366185,49.36458938258917,"['CHRM3', 'ADGRE2', 'P2RY13', 'ADRB2', 'GRM1', 'ADGRL2', 'GPR135']",0.032576539966471266,0,0,7
8,Monoamine GPCRs WP58,0.0006018760270941573,22.358638743455497,165.79957043891966,"['CHRM3', 'HRH1', 'HRH2', 'ADRB2']",0.032576539966471266,0,0,4
9,Nonalcoholic fatty liver disease WP4396,0.0008255977030808889,2.373534136546185,16.85067523991291,"['XBP1', 'NDUFA7', 'NDUFA4', 'INSR', 'COX4I1', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'VMP1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFAB1', 'LEPR', 'CYCS', 'UQCRFS1']",0.03972042282600277,0,0,21
10,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.0018262785911949515,7.991012918929039,50.38713170022361,"['STAT3', 'SPP1', 'HSPB1', 'IGF1', 'TLR4']",0.0790778629987414,0,0,5
11,Photodynamic therapy-induced unfolded protein response WP3613,0.003288276636199242,5.1665657177468205,29.539279798342946,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB11', 'CALR', 'HSP90B1']",0.12943852577038836,0,0,6
12,Spinal Cord Injury WP2431,0.003999095726520004,2.872415593990968,15.8605798778017,"['ZFP36', 'C5', 'GAP43', 'FCGR2A', 'APEX1', 'TNFSF13', 'OMG', 'MIF', 'LILRB3', 'TLR4', 'TNFSF13B']",0.14430070413193016,0,0,11
13,Nuclear Receptors Meta-Pathway WP2882,0.004784171790474568,1.9700200008511,10.524718289982866,"['ABCC3', 'CPT1A', 'HSP90AA1', 'SERPINA1', 'STAT3', 'PDGFB', 'MGST1', 'SLC2A3', 'NRG1', 'SLC5A3', 'SLC7A5', 'DNAJB1', 'SLC5A9', 'SEC14L1', 'FTH1', 'BHLHE40', 'PDE4B', 'HMOX1', 'PLTP', 'CPEB4', 'HSPA1A', 'FKBP5']",0.14867374217691126,0,0,22
14,NRF2 pathway WP2884,0.00480700321126272,2.6430127606598193,14.107560110766615,"['ABCC3', 'DNAJB1', 'HSP90AA1', 'SLC5A9', 'SERPINA1', 'FTH1', 'PDGFB', 'HMOX1', 'SLC2A3', 'NRG1', 'SLC5A3', 'HSPA1A']",0.14867374217691126,0,0,12
15,Thyroxine (Thyroid Hormone) Production WP1981,0.0067952496471197854,inf,inf,"['TG', 'TSHR']",0.19615620648019114,0,0,2
16,Lung fibrosis WP3624,0.0073068422289747584,4.196358267716535,20.641651650867917,"['CEBPB', 'SERPINA1', 'PDGFB', 'SPP1', 'HMOX1', 'IGF1']",0.1977414178216294,0,0,6
17,PI3K-Akt signaling pathway WP4172,0.008904941209905077,1.8506462326437518,8.737176544313376,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'IL4R', 'INSR', 'PDGFB', 'LPAR1', 'IGF1', 'HSP90B1', 'GNG10', 'CCND3', 'GNG3', 'FGF14', 'DDIT4', 'PDGFC', 'IL3RA', 'SPP1', 'FGF20', 'SGK1', 'JAK3', 'TLR4', 'TLR2']",0.21574997495132392,0,0,22
18,HIF1A and PPARG regulation of glycolysis WP2456,0.009247795698103585,11.163398692810457,52.2823271919556,"['LDHA', 'TPI1', 'HIF1A']",0.21574997495132392,0,0,3
19,IL1 and megakaryocytes in obesity WP2865,0.009467088970150472,6.3844427823485415,29.751080804727703,"['NLRP3', 'PLA2G7', 'S100A9', 'TLR2']",0.21574997495132392,0,0,4
20,Vitamin D Receptor Pathway WP2877,0.01031879654551386,2.468243064729194,11.289220854948981,"['CDKN1A', 'DUSP10', 'BCL6', 'SPP1', 'CD9', 'ADRB2', 'CD14', 'MXD1', 'S100A9', 'HIF1A', 'S100A8']",0.22340194521037504,0,0,11
21,Selenium Micronutrient Network WP15,0.01277842692646986,2.890322580645161,12.60179756764114,"['SELENOM', 'PRDX5', 'RFK', 'INSR', 'SELENOW', 'PLAT', 'ALOX15B', 'SELENOH']",0.22384975547994893,0,0,8
22,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.013997161772863797,1.7913167822806377,7.646953466568421,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'IL4R', 'INSR', 'PDGFB', 'LPAR1', 'SLC2A3', 'IGF1', 'HIF1A', 'HSP90B1', 'GNG10', 'GNG3', 'FGF14', 'DDIT4', 'PDGFC', 'IL3RA', 'SPP1', 'FGF20', 'ITGAX', 'JAK3']",0.22384975547994893,0,0,21
23,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.014031565724764756,3.532532117695814,15.071356791299358,"['TICAM2', 'IRAK2', 'LY96', 'PLAT', 'CD14', 'TLR4']",0.22384975547994893,0,0,6
24,ESC Pluripotency Pathways WP3931,0.015103478942650602,2.436904898474246,10.217528375222555,"['FGF14', 'WNT2B', 'WNT5B', 'WNT5A', 'STAT3', 'PDGFB', 'FGF20', 'GAB1', 'SMAD6', 'MAP2K6']",0.22384975547994893,0,0,10
25,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.015199147488642345,8.37156862745098,35.04770549305773,"['CDKN1A', 'SPP1', 'ENPP1']",0.22384975547994893,0,0,3
26,Genes targeted by miRNAs in adipocytes WP1992,0.015199147488642345,8.37156862745098,35.04770549305773,"['TMSB4X', 'IGF1', 'KCNJ2']",0.22384975547994893,0,0,3
27,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.015199147488642345,8.37156862745098,35.04770549305773,"['GRM5', 'GRM7', 'GRM1']",0.22384975547994893,0,0,3
28,Platelet-mediated interactions with vascular and circulating cells WP4462,0.015199147488642345,8.37156862745098,35.04770549305773,"['SELPLG', 'TLR4', 'TLR2']",0.22384975547994893,0,0,3
29,Transcriptional cascade regulating adipogenesis WP4211,0.015199147488642345,8.37156862745098,35.04770549305773,"['CEBPB', 'CEBPD', 'DDIT3']",0.22384975547994893,0,0,3
30,Adipogenesis WP236,0.01637783843507297,2.284333871520133,9.392783800640576,"['CDKN1A', 'CEBPB', 'WNT5B', 'CEBPD', 'DDIT3', 'NAMPT', 'STAT3', 'RORA', 'MIF', 'IGF1', 'HIF1A']",0.22384975547994893,0,0,11
31,Toll-like Receptor Signaling Pathway WP75,0.01637783843507297,2.284333871520133,9.392783800640576,"['IFNAR2', 'TICAM2', 'SPP1', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.22384975547994893,0,0,11
32,IL-18 signaling pathway WP4754,0.016543168996208696,1.7861386979034037,7.326351581706804,"['SPON1', 'CPT1A', 'CEBPB', 'NRN1', 'TICAM2', 'SEMA6D', 'RGS16', 'TNFAIP2', 'HSPB1', 'PLA2G7', 'GRIN2B', 'GRM7', 'TMSB4X', 'STMN1', 'SPP1', 'HMOX1', 'CYCS', 'KIFC3', 'RPS11', 'IER3']",0.22384975547994893,0,0,20
33,Differentiation Pathway WP2848,0.0179628855089652,4.964514252472368,19.954604728126437,"['WNT2B', 'WNT5A', 'PDGFB', 'IGF1']",0.2287626301582921,0,0,4
34,Mitochondrial complex III assembly WP4921,0.0179628855089652,4.964514252472368,19.954604728126437,"['UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10']",0.2287626301582921,0,0,4
35,EV release from cardiac cells and their functional effects WP3297,0.019267514394002455,22.302872062663184,88.08150862650507,"['CXCL12', 'RGS16']",0.2362671048579389,0,0,2
36,Oxidative phosphorylation WP623,0.01964345444546374,2.4588836402198013,9.663440007689275,"['NDUFA7', 'NDUFS6', 'NDUFA4', 'NDUFAB1', 'NDUFB2', 'ATP5MC3', 'ATP5MF', 'ATP5F1E', 'ATP5MC1']",0.2362671048579389,0,0,9
37,Regulatory circuits of the STAT3 signaling pathway WP4538,0.022530501382064767,2.558796992481203,9.705223423775506,"['PTPRT', 'IFNAR2', 'STMN1', 'IL3RA', 'STAT3', 'IL21R', 'JAK3', 'CSF2RA']",0.2613706517932102,0,0,8
38,Pre-implantation embryo WP3527,0.023541467482529325,4.467539267015707,16.748768253072875,"['ESRRA', 'ZFP36', 'DDIT3', 'MXD1']",0.2613706517932102,0,0,4
39,Striated Muscle Contraction Pathway WP383,0.023541467482529325,4.467539267015707,16.748768253072875,"['TMOD1', 'MYOM1', 'ACTG1', 'TTN']",0.2613706517932102,0,0,4
40,Myometrial relaxation and contraction pathways WP289,0.025272785138202705,1.9158633628776607,7.046597461387389,"['RYR2', 'GUCY1A1', 'PDE4D', 'RGS16', 'LPAR1', 'ACTG1', 'RGS4', 'GNG3', 'ADCY9', 'PDE4B', 'CALM3', 'CALM2', 'RGS6', 'YWHAH']",0.27357789912104424,0,0,14
41,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.029353159056533414,2.6102058694699957,9.209733203462246,"['PPP1R14A', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'HSPA5', 'PPP1R3B', 'DDIT3']",0.2845724468483367,0,0,7
42,Calcium Regulation in the Cardiac Cell WP536,0.029623777499967696,1.8698054818744474,6.580178215500485,"['CHRM3', 'RYR2', 'RGS16', 'CACNA1B', 'CACNA1A', 'ADRB2', 'RGS4', 'GNG3', 'ADCY9', 'CALM3', 'CALR', 'CALM2', 'RGS6', 'YWHAH']",0.2845724468483367,0,0,14
43,Regulation of toll-like receptor signaling pathway WP1449,0.030037510028956237,1.9182816312303939,6.724168608167523,"['IFNAR2', 'TICAM2', 'LY96', 'SMAD6', 'IRAK2', 'SPP1', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.2845724468483367,0,0,13
44,White fat cell differentiation WP4149,0.030058027097706497,4.060923369823893,14.232015713021623,"['CEBPB', 'CEBPD', 'DDIT3', 'RORA']",0.2845724468483367,0,0,4
45,Cori Cycle WP1946,0.03220334848861085,5.579738562091503,19.170223197360244,"['LDHA', 'TPI1', 'PGAM1']",0.2845724468483367,0,0,3
46,Leptin Insulin Overlap WP3935,0.03220334848861085,5.579738562091503,19.170223197360244,"['INSR', 'STAT3', 'LEPR']",0.2845724468483367,0,0,3
47,LTF danger signal response pathway WP4478,0.03220334848861085,5.579738562091503,19.170223197360244,"['CD14', 'TLR4', 'TLR2']",0.2845724468483367,0,0,3
48,Peptide GPCRs WP24,0.03220334848861085,5.579738562091503,19.170223197360244,"['CX3CR1', 'OPRM1', 'TSHR']",0.2845724468483367,0,0,3
49,Pyrimidine metabolism and related diseases WP4225,0.03220334848861085,5.579738562091503,19.170223197360244,"['NT5C', 'DPYD', 'TYMP']",0.2845724468483367,0,0,3
50,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.03351445957540233,2.5257089568055613,8.576747678142102,"['BEX3', 'CDKN1A', 'HSPA5', 'HSPB1', 'NRG1', 'YBX3', 'IER3']",0.29023521992298423,0,0,7
51,Pyrimidine metabolism WP4022,0.03460090590224642,2.1903247980752707,7.367979739362907,"['NT5C', 'POLE4', 'PRIM1', 'DPYD', 'ENPP1', 'POLR2I', 'POLR2K', 'NME1', 'TYMP']",0.2937684756014255,0,0,9
52,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.036436341953824045,11.150130548302872,36.9313352581504,"['CDKN1A', 'HIF1A']",0.2976780389812417,0,0,2
53,miR-517 relationship with ARCN1 and USP1 WP3596,0.036436341953824045,11.150130548302872,36.9313352581504,"['CDKN1A', 'ID2']",0.2976780389812417,0,0,2
54,Phosphodiesterases in neuronal function WP4222,0.03833566949081142,2.6828346456692915,8.7497284954829,"['GUCY1A1', 'ADCY9', 'PDE4D', 'PDE4B', 'PDE7B', 'GRIN2B']",0.3073952757318768,0,0,6
55,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.04295211383684023,2.939918603849072,9.253891873508367,"['IFNAR2', 'OAS1', 'IKBKE', 'TLR4', 'TLR2']",0.32304433413066413,0,0,5
56,Biomarkers for pyrimidine metabolism disorders WP4584,0.0432448338368535,4.7820728291316525,15.01990496002132,"['NT5C', 'DPYD', 'TYMP']",0.32304433413066413,0,0,3
57,Iron metabolism in placenta WP2007,0.0432448338368535,4.7820728291316525,15.01990496002132,"['FTH1', 'SLC40A1', 'HAMP']",0.32304433413066413,0,0,3
58,Endochondral Ossification with Skeletal Dysplasias WP4808,0.04401758825336994,2.5793458509993945,8.05572524320181,"['SCIN', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'CALM2']",0.32304433413066413,0,0,6
59,Endochondral Ossification WP474,0.04401758825336994,2.5793458509993945,8.05572524320181,"['SCIN', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'CALM2']",0.32304433413066413,0,0,6
60,Toll-like Receptor Signaling related to MyD88 WP3858,0.0501822586249918,2.79259501965924,8.355706044827008,"['TICAM2', 'TLR5', 'IKBKE', 'TLR4', 'TLR2']",0.35783753000841834,0,0,5
61,Retinoblastoma gene in cancer WP2446,0.05041129175638226,2.130576441102757,6.365182524536133,"['CDKN1A', 'CCND3', 'H2AFZ', 'PRIM1', 'RPA3', 'STMN1', 'HMGB2', 'SAP30']",0.35783753000841834,0,0,8
62,Complement and Coagulation Cascades WP558,0.055391403394627725,3.1896035901271502,9.22857853245639,"['SERPINA1', 'PROS1', 'PLAT', 'CD55']",0.37124293908614775,0,0,4
63,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.055911505384648806,4.1838235294117645,12.066084716358532,"['IL4R', 'STAT3', 'TLR4']",0.37124293908614775,0,0,3
64,Inflammatory Response Pathway WP453,0.057444057549126785,7.432550043516101,21.23437714777093,"['IL4R', 'TNFRSF1B']",0.37124293908614775,0,0,2
65,Insulin signaling in adipocytes (diabetic condition) WP3635,0.057444057549126785,7.432550043516101,21.23437714777093,"['TBC1D4', 'INSR']",0.37124293908614775,0,0,2
66,Insulin signaling in adipocytes (normal condition) WP3634,0.057444057549126785,7.432550043516101,21.23437714777093,"['TBC1D4', 'INSR']",0.37124293908614775,0,0,2
67,PTF1A related regulatory pathway WP4147,0.057444057549126785,7.432550043516101,21.23437714777093,"['PROX1', 'RBPJ']",0.37124293908614775,0,0,2
68,MAPK Signaling Pathway WP382,0.06751246641514118,1.5115946557585054,4.074417249610591,"['LRRK2', 'HSPA6', 'CACNA2D3', 'PDGFB', 'CACNA1B', 'CACNA1A', 'HSPB1', 'RASGRP3', 'RPS6KA5', 'FGF14', 'DUSP10', 'DDIT3', 'STMN1', 'FGF20', 'MAP3K8', 'CD14', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.42169101208264315,0,0,19
69,Airway smooth muscle cell contraction WP4962,0.07011952163960809,3.7185185185185183,9.882163915338026,"['PPP1R14A', 'ADRB2', 'CALM2']",0.42169101208264315,0,0,3
70,Genes controlling nephrogenesis WP4823,0.07011952163960809,3.7185185185185183,9.882163915338026,"['ROBO2', 'CXCL12', 'PDGFB']",0.42169101208264315,0,0,3
71,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.07011952163960809,3.7185185185185183,9.882163915338026,"['PDGFB', 'OMG', 'IGF1']",0.42169101208264315,0,0,3
72,Type II diabetes mellitus WP1584,0.07011952163960809,3.7185185185185183,9.882163915338026,"['GK', 'INSR', 'CACNA1A']",0.42169101208264315,0,0,3
73,Glycolysis and Gluconeogenesis WP534,0.0758843790470669,2.4274887457974814,6.259387573243041,"['LDHA', 'TPI1', 'MPC2', 'PGAM1', 'SLC2A3']",0.42686099014968565,0,0,5
74,NO/cGMP/PKG mediated Neuroprotection WP4008,0.0758843790470669,2.4274887457974814,6.259387573243041,"['GUCY1A1', 'TSPO', 'CYCS', 'GRIN2B', 'CALM2']",0.42686099014968565,0,0,5
75,Glucocorticoid Receptor Pathway WP2880,0.07999878224913817,2.162052324104648,5.460790396248341,"['HSP90AA1', 'MGAM', 'SEC14L1', 'BHLHE40', 'PDE4B', 'CPEB4']",0.42686099014968565,0,0,6
76,Caloric restriction and aging WP4191,0.08154222025364188,5.573759791122716,13.971377767517893,"['NAMPT', 'IGF1']",0.42686099014968565,0,0,2
77,Cells and molecules involved in local acute inflammatory response  WP4493,0.08154222025364188,5.573759791122716,13.971377767517893,"['C5', 'SELPLG']",0.42686099014968565,0,0,2
78,Macrophage markers WP4146,0.08154222025364188,5.573759791122716,13.971377767517893,"['CD163', 'CD14']",0.42686099014968565,0,0,2
79,Major receptors targeted by epinephrine and norepinephrine WP4589,0.08154222025364188,5.573759791122716,13.971377767517893,"['ADCY9', 'ADRB2']",0.42686099014968565,0,0,2
80,Nanomaterial-induced inflammasome activation WP3890,0.08154222025364188,5.573759791122716,13.971377767517893,"['CASP1', 'TLR4']",0.42686099014968565,0,0,2
81,Codeine and Morphine Metabolism WP1604,0.08248283965211296,inf,inf,['ABCC3'],0.42686099014968565,0,0,1
82,"COVID-19, thrombosis and anticoagulation WP4927",0.08248283965211296,inf,inf,['F13A1'],0.42686099014968565,0,0,1
83,Cardiac Progenitor Differentiation WP2406,0.08576652688919781,3.3462745098039215,8.218873426537442,"['NRG1', 'ROR2', 'IGF1']",0.42686099014968565,0,0,3
84,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.08576652688919781,3.3462745098039215,8.218873426537442,"['CYSLTR1', 'LTC4S', 'ALOX15B']",0.42686099014968565,0,0,3
85,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.08576652688919781,3.3462745098039215,8.218873426537442,"['TLR5', 'TLR4', 'TLR2']",0.42686099014968565,0,0,3
86,Transcription factor regulation in adipogenesis WP3599,0.08576652688919781,3.3462745098039215,8.218873426537442,"['CEBPB', 'CEBPD', 'INSR']",0.42686099014968565,0,0,3
87,Wnt signaling in kidney disease WP4150,0.08576652688919781,3.3462745098039215,8.218873426537442,"['WNT2B', 'WNT5B', 'WNT5A']",0.42686099014968565,0,0,3
88,Genotoxicity pathway WP4286,0.08871459789988943,2.094242125984252,5.072947261203618,"['ITPKC', 'PLK3', 'CDKN1A', 'RPS27', 'CEBPD', 'ID2']",0.4342281693241906,0,0,6
89,Unfolded protein response WP4925,0.08925244126986828,2.6258084385586695,6.344705496203175,"['XBP1', 'HSPA5', 'DDIT3', 'TXNIP']",0.4342281693241906,0,0,4
90,CAMKK2  Pathway WP4874,0.0962959866521598,2.2327653997378767,5.2254048036316085,"['CHRM3', 'FIS1', 'MAP1LC3A', 'HMOX1', 'CALM2']",0.46329069133761325,0,0,5
91,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.10807947467472126,4.458485639686684,9.919633185792009,"['CASP1', 'NLRP3']",0.4926148687805717,0,0,2
92,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.10807947467472126,4.458485639686684,9.919633185792009,"['TLR4', 'TLR2']",0.4926148687805717,0,0,2
93,Complement Activation WP545,0.10807947467472126,4.458485639686684,9.919633185792009,"['C5', 'CD55']",0.4926148687805717,0,0,2
94,Dual hijack model of Vif in HIV infection WP3300,0.10807947467472126,4.458485639686684,9.919633185792009,"['ELOB', 'RUNX1']",0.4926148687805717,0,0,2
95,"GPCRs, Class B Secretin-like WP334",0.10807947467472126,4.458485639686684,9.919633185792009,"['ADGRE2', 'ADGRL2']",0.4926148687805717,0,0,2
96,Cell migration and invasion through p75NTR WP4561,0.1209067673798961,2.787908496732026,5.8901133853608245,"['TIAM1', 'PARD3', 'STAT3']",0.5397178378917011,0,0,3
97,Immune response to tuberculosis WP4197,0.1209067673798961,2.787908496732026,5.8901133853608245,"['IFNAR2', 'OAS1', 'PTPN2']",0.5397178378917011,0,0,3
98,Type 2 papillary renal cell carcinoma WP4241,0.1308401512641529,2.231151832460733,4.537669564651909,"['CDKN1A', 'PDGFB', 'ELOB', 'HIF1A']",0.5618839897537206,0,0,4
99,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.1315069475405154,1.9928384197715783,4.042862525236396,"['CCND3', 'WNT2B', 'WNT5B', 'WNT5A', 'ROR2']",0.5618839897537206,0,0,5
100,PPAR signaling pathway WP3942,0.1315069475405154,1.9928384197715783,4.042862525236396,"['CPT1A', 'FABP5', 'ACSL1', 'OLR1', 'PLTP']",0.5618839897537206,0,0,5
101,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.13649065945488112,3.71496953872933,7.398358476562706,"['ID2', 'STAT3']",0.5618839897537206,0,0,2
102,Fatty acid transporters WP5061,0.13649065945488112,3.71496953872933,7.398358476562706,"['FABP5', 'ACSL1']",0.5618839897537206,0,0,2
103,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.13649065945488112,3.71496953872933,7.398358476562706,"['STAT3', 'HMOX1']",0.5618839897537206,0,0,2
104,Leptin and adiponectin WP3934,0.13649065945488112,3.71496953872933,7.398358476562706,"['CPT1A', 'LEPR']",0.5618839897537206,0,0,2
105,Osteoclast Signaling WP12,0.13649065945488112,3.71496953872933,7.398358476562706,"['PDGFB', 'SPP1']",0.5618839897537206,0,0,2
106,Fluoropyrimidine Activity WP1601,0.14014658404942681,2.5731523378582204,5.056415137394598,"['ABCC3', 'DPYD', 'TYMP']",0.5618839897537206,0,0,3
107,Statin inhibition of cholesterol production WP430,0.14014658404942681,2.5731523378582204,5.056415137394598,"['APOC2', 'APOC1', 'PLTP']",0.5618839897537206,0,0,3
108,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.14014658404942681,2.5731523378582204,5.056415137394598,"['FCGR2A', 'NLRP3', 'IKBKE']",0.5618839897537206,0,0,3
109,Ferroptosis WP4313,0.1443727557007166,1.9238938852985041,3.7234210032614303,"['MAP1LC3A', 'ACSL1', 'FTH1', 'SLC40A1', 'HMOX1']",0.5714467615337986,0,0,5
110,IL-4 signaling pathway WP395,0.1510116438517627,1.7623290509738914,3.331503901108556,"['CEBPB', 'HRH1', 'IL4R', 'NFIL3', 'STAT3', 'JAK3']",0.5714467615337986,0,0,6
111,Circadian rhythm related genes WP3594,0.15174298244565665,1.424918841708869,2.6867800799629302,"['CPT1A', 'KCNH7', 'RORA', 'PROX1', 'CARTPT', 'ARNTL', 'PER3', 'NFIL3', 'ID2', 'NAMPT', 'KCNMA1', 'BHLHE40', 'RPS27A']",0.5714467615337986,0,0,13
112,Blood Clotting Cascade WP272,0.1581705006413664,11.136897001303781,20.537348064043158,['PLAT'],0.5714467615337986,0,0,1
113,Drug Induction of Bile Acid Pathway WP2289,0.1581705006413664,11.136897001303781,20.537348064043158,['ABCC3'],0.5714467615337986,0,0,1
114,Hfe effect on hepcidin production WP3924,0.1581705006413664,11.136897001303781,20.537348064043158,['HAMP'],0.5714467615337986,0,0,1
115,Osteoblast Signaling WP322,0.1581705006413664,11.136897001303781,20.537348064043158,['PDGFB'],0.5714467615337986,0,0,1
116,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.1581705006413664,11.136897001303781,20.537348064043158,['HRH2'],0.5714467615337986,0,0,1
117,Small Ligand GPCRs WP247,0.1581705006413664,11.136897001303781,20.537348064043158,['LPAR1'],0.5714467615337986,0,0,1
118,NRF2-ARE regulation WP4357,0.16032525584351287,2.389075630252101,4.373324015152524,"['CEBPB', 'INSR', 'HMOX1']",0.5714467615337986,0,0,3
119,Fatty acid beta-oxidation WP143,0.1622256106838853,2.027843883864826,3.688176052312596,"['CPT1A', 'TPI1', 'GK', 'ACSL1']",0.5714467615337986,0,0,4
120,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.1622256106838853,2.027843883864826,3.688176052312596,"['HSP90AA1', 'CASP1', 'NLRP3', 'NLRP1']",0.5714467615337986,0,0,4
121,Oxidative Damage WP3941,0.1622256106838853,2.027843883864826,3.688176052312596,"['CDKN1A', 'C5', 'CYCS', 'TNFRSF1B']",0.5714467615337986,0,0,4
122,Cell Differentiation - Index expanded WP2023,0.16628704839089753,3.1838866094740768,5.712019222245833,"['ID2', 'STAT3']",0.5714467615337986,0,0,2
123,Computational Model of Aerobic Glycolysis WP4629,0.16628704839089753,3.1838866094740768,5.712019222245833,"['LDHA', 'TPI1']",0.5714467615337986,0,0,2
124,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.16628704839089753,3.1838866094740768,5.712019222245833,"['STAT3', 'JAK3']",0.5714467615337986,0,0,2
125,NOTCH1 regulation of endothelial cell calcification WP3413,0.16628704839089753,3.1838866094740768,5.712019222245833,"['LPAR1', 'PLAT']",0.5714467615337986,0,0,2
126,Overview of nanoparticle effects WP3287,0.16628704839089753,3.1838866094740768,5.712019222245833,"['CCND3', 'HMOX1']",0.5714467615337986,0,0,2
127,Chemokine signaling pathway WP3929,0.17437947693890146,1.4289422751989187,2.4956783380683665,"['FGR', 'CX3CR1', 'TIAM1', 'GNG10', 'GNG3', 'ADCY9', 'CXCL12', 'PARD3', 'PXN', 'STAT3', 'JAK3']",0.5945379016893255,0,0,11
128,p38 MAPK Signaling Pathway WP400,0.19600765665517986,1.8584205933682374,3.0284850905575253,"['RPS6KA5', 'DDIT3', 'HSPB1', 'MAP2K6']",0.636728477160141,0,0,4
129,Development of ureteric collection system WP5053,0.19704761186942008,2.785574412532637,4.524636081058754,"['ROBO2', 'GRIP1']",0.636728477160141,0,0,2
130,Kynurenine Pathway and links to Cellular Senescence WP5044,0.19704761186942008,2.785574412532637,4.524636081058754,"['CDKN1A', 'TLR4']",0.636728477160141,0,0,2
131,miRNAs involved in DNA damage response WP1545,0.19704761186942008,2.785574412532637,4.524636081058754,"['CDKN1A', 'CCND3']",0.636728477160141,0,0,2
132,"NAD metabolism, sirtuins and aging WP3630",0.19704761186942008,2.785574412532637,4.524636081058754,"['NAMPT', 'HIF1A']",0.636728477160141,0,0,2
133,PPAR-alpha pathway WP2878,0.19704761186942008,2.785574412532637,4.524636081058754,"['CPT1A', 'PLTP']",0.636728477160141,0,0,2
134,Proteoglycan biosynthesis WP4784,0.19704761186942008,2.785574412532637,4.524636081058754,"['CSGALNACT1', 'CHSY1']",0.636728477160141,0,0,2
135,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.20171074193706276,1.4352907961603614,2.297786571617603,"['RYR2', 'SNAP25', 'CPT1A', 'CEBPB', 'BHLHE40', 'RORA', 'HIF1A', 'HSP90B1', 'YWHAH']",0.6415308154129785,0,0,9
136,Nanoparticle triggered autophagic cell death WP2509,0.2029785720821664,2.0899509803921568,3.332750491716763,"['VMP1', 'MAP1LC3A', 'INSR']",0.6415308154129785,0,0,3
137,Neovascularisation processes WP4331,0.2029785720821664,2.0899509803921568,3.332750491716763,"['CXCL12', 'PDGFB', 'HIF1A']",0.6415308154129785,0,0,3
138,Disruption of postsynaptic signaling by CNV WP4875,0.21364558301452366,1.7838743455497381,2.7532972955091672,"['RYR2', 'DLGAP1', 'GRIN2B', 'GRM1']",0.6600383323477012,0,0,4
139,VEGFA-VEGFR2 Signaling Pathway WP3888,0.21566397979173213,1.1843512811369772,1.816834815432948,"['PXN', 'HTRA1', 'HSPB1', 'IQGAP1', 'ADRB2', 'LDB2', 'RPL10A', 'SLC7A1', 'RPL7', 'ACTG1', 'LDHA', 'RPS6KA5', 'TMSB4X', 'RPS11', 'TMSB10', 'CLIC1', 'MAP2K6', 'TMOD1', 'PTPN1', 'HSP90AA1', 'SDF2L1', 'SEMA6D', 'STAT3', 'GAB1', 'PTPN14', 'KATNAL2', 'TXNIP', 'CYCS', 'RPL26', 'CALR', 'HSPA1A']",0.6600383323477012,0,0,31
140,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.21766000865676458,1.4398981324278437,2.1955869489808717,"['WNT2B', 'WNT5B', 'ID2', 'WNT5A', 'PROX1', 'RBPJ', 'HIF1A', 'MAP2K6']",0.6600383323477012,0,0,8
141,Insulin Signaling WP481,0.22152306672303113,1.3079887834854722,1.9714380456776677,"['SNAP25', 'PTPN1', 'XBP1', 'INSR', 'GAB1', 'RPS6KA5', 'TBC1D4', 'ENPP1', 'FLOT2', 'MAP3K8', 'SGK1', 'SH2B2', 'MAP2K6']",0.6600383323477012,0,0,13
142,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.22307664264080126,1.473483251927702,2.2105783335137477,"['WNT5A', 'STAT3', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.6600383323477012,0,0,7
143,Folate Metabolism WP176,0.22520047945097238,1.9667820069204152,2.9320083107729045,"['RFK', 'INSR', 'PLAT']",0.6600383323477012,0,0,3
144,IL17 signaling pathway WP2112,0.22520047945097238,1.9667820069204152,2.9320083107729045,"['CEBPB', 'CEBPD', 'STAT3']",0.6600383323477012,0,0,3
145,Dopaminergic Neurogenesis WP2855,0.22762202209729213,5.567796610169491,8.240722178378743,['STAT3'],0.6600383323477012,0,0,1
146,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.22762202209729213,5.567796610169491,8.240722178378743,['CEBPB'],0.6600383323477012,0,0,1
147,Nephrogenesis WP5052,0.22762202209729213,5.567796610169491,8.240722178378743,['FGF20'],0.6600383323477012,0,0,1
148,ERK Pathway in Huntington's Disease WP3853,0.2284111969530162,2.4757760371337394,3.655750155406493,"['RPS6KA5', 'GRM1']",0.6600383323477012,0,0,2
149,Phytochemical activity on NRF2 transcriptional activation WP3,0.2284111969530162,2.4757760371337394,3.655750155406493,"['CEBPB', 'HMOX1']",0.6600383323477012,0,0,2
150,Allograft Rejection WP2328,0.2312264698486414,1.5929601198277477,2.332663353181984,"['C5', 'CXCL12', 'GNLY', 'LRRK2', 'CD55']",0.6600383323477012,0,0,5
151,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.2312264698486414,1.5929601198277477,2.332663353181984,"['CCND3', 'WNT2B', 'WNT5B', 'WNT5A', 'ROR2']",0.6600383323477012,0,0,5
152,Fas ligand pathway and stress induction of heat shock proteins WP314,0.231699368399193,1.7150624244865083,2.507960777771231,"['HSPB1', 'CYCS', 'ACTG1', 'LMNB1']",0.6600383323477012,0,0,4
153,MECP2 and Associated Rett Syndrome WP3584,0.24172038291583717,1.4869641294838145,2.1114499022285047,"['RBFOX1', 'CEBPD', 'BCL6', 'IGF1', 'SGK1', 'FKBP5']",0.6840844823696569,0,0,6
154,Aryl Hydrocarbon Receptor Pathway WP2873,0.24785848716935624,1.8572984749455337,2.590740650159087,"['SLC7A5', 'HSP90AA1', 'MGST1']",0.6897878566864901,0,0,3
155,The influence of laminopathies on Wnt signaling WP4844,0.24785848716935624,1.8572984749455337,2.590740650159087,"['CEBPB', 'CEBPD', 'SPP1']",0.6897878566864901,0,0,3
156,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.2501078371819375,1.6513476827612954,2.2885418277204854,"['IFITM3', 'IFITM2', 'DDIT3', 'MAP2K6']",0.6897878566864901,0,0,4
157,Metabolic reprogramming in colon cancer WP4290,0.2501078371819375,1.6513476827612954,2.2885418277204854,"['LDHA', 'PGAM1', 'SLC16A3', 'PAICS']",0.6897878566864901,0,0,4
158,Eicosanoid Synthesis WP167,0.26006953443540715,2.2279373368146214,3.0005999155406675,"['LTC4S', 'ALOX15B']",0.6994416671461571,0,0,2
159,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.26006953443540715,2.2279373368146214,3.0005999155406675,"['CPT1A', 'ACSL1']",0.6994416671461571,0,0,2
160,Pregnane X receptor pathway WP2876,0.26006953443540715,2.2279373368146214,3.0005999155406675,"['ABCC3', 'HSP90AA1']",0.6994416671461571,0,0,2
161,Vitamin B12 metabolism WP1533,0.26006953443540715,2.2279373368146214,3.0005999155406675,"['INSR', 'PLAT']",0.6994416671461571,0,0,2
162,Notch Signaling Pathway Netpath WP61,0.2630010278867975,1.5064999468669193,2.0120773194816164,"['CDKN1A', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.702959537499897,0,0,5
163,Ectoderm Differentiation WP2858,0.26592735969242665,1.3210422300811318,1.7497628277811799,"['PLCXD3', 'MAFB', 'ZBTB16', 'PIM1', 'HMGB2', 'SORCS1', 'ROR2', 'LDB2', 'KIFC3']",0.7064205321890843,0,0,9
164,Acute viral myocarditis WP4298,0.27019301498824927,1.4233539956441614,1.8626276626147154,"['STAT3', 'CASP1', 'CYCS', 'TLR5', 'TLR4', 'CD55']",0.7064664668037796,0,0,6
165,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.27019301498824927,1.4233539956441614,1.8626276626147154,"['CCND3', 'PDE4D', 'APEX1', 'STAT3', 'TSHR', 'MAP2K6']",0.7064664668037796,0,0,6
166,Melatonin metabolism and effects WP3298,0.27083933831276535,1.7593395252837978,2.298101155824251,"['PER3', 'CALM2', 'ARNTL']",0.7064664668037796,0,0,3
167,Pathogenic Escherichia coli infection WP2272,0.2792502249939379,1.4666827619507485,1.870969517045088,"['LY96', 'CD14', 'TLR5', 'TLR4', 'ACTG1']",0.7193094262708394,0,0,5
168,TYROBP causal network in microglia WP3945,0.28472819954013767,1.3935367454068242,1.7505890641857802,"['IGSF6', 'DPYD', 'ITGAX', 'SPP1', 'TNFRSF1B', 'GAL3ST4']",0.7193094262708394,0,0,6
169,Common Pathways Underlying Drug Addiction WP2636,0.2877491933387346,1.53710055966781,1.91471395913452,"['GRM5', 'CALM2', 'GRM1', 'ACTG1']",0.7193094262708394,0,0,4
170,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.2877491933387346,1.53710055966781,1.91471395913452,"['CDKN1A', 'CEBPB', 'CEBPD', 'SPP1']",0.7193094262708394,0,0,4
171,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.29135058814215986,3.7114298131247283,4.5770390420488685,['HIF1A'],0.7193094262708394,0,0,1
172,miR-509-3p alteration of YAP1/ECM axis WP3967,0.29135058814215986,3.7114298131247283,4.5770390420488685,['GPC6'],0.7193094262708394,0,0,1
173,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.29135058814215986,3.7114298131247283,4.5770390420488685,['STAT3'],0.7193094262708394,0,0,1
174,Constitutive Androstane Receptor Pathway WP2875,0.2917609897115403,2.0251602183717066,2.4946335493085883,"['ABCC3', 'HSP90AA1']",0.7193094262708394,0,0,2
175,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.2917609897115403,2.0251602183717066,2.4946335493085883,"['LDHA', 'SLC2A3']",0.7193094262708394,0,0,2
176,Bladder cancer WP2828,0.2940364167435071,1.6711764705882353,2.0456063210104456,"['CDKN1A', 'RPS6KA5', 'TYMP']",0.7193094262708394,0,0,3
177,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.2940364167435071,1.6711764705882353,2.0456063210104456,"['LDHA', 'SLC2A3', 'HIF1A']",0.7193094262708394,0,0,3
178,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.29942799745124643,1.364936525791419,1.6459514314664176,"['HSPA5', 'HSPA6', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.7283838364965713,0,0,6
179,G1 to S cell cycle control WP45,0.306866049684915,1.4856893542757417,1.7551101255804,"['CDKN1A', 'CCND3', 'PRIM1', 'RPA3']",0.7423072598523363,0,0,4
180,3q29 copy number variation syndrome WP4906,0.3122869688587504,1.3930209698558322,1.621243414900123,"['PXN', 'SLC40A1', 'DYNLL1', 'HIF1A', 'HAMP']",0.7438973144506241,0,0,5
181,Cardiac Hypertrophic Response WP2795,0.3122869688587504,1.3930209698558322,1.621243414900123,"['NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.7438973144506241,0,0,5
182,Pathways in clear cell renal cell carcinoma WP4018,0.31426659893590037,1.33748031496063,1.5481516704938783,"['LDHA', 'TPI1', 'STAT3', 'PDGFB', 'HIF1A', 'KCNJ2']",0.7438973144506241,0,0,6
183,TNF-alpha signaling pathway WP231,0.31439540079552936,1.300503723171266,1.5048178611804586,"['HSP90AA1', 'RFK', 'MAP3K8', 'PYGL', 'KSR2', 'TNFRSF1B', 'MAP2K6']",0.7438973144506241,0,0,7
184,Apoptosis Modulation by HSP70 WP384,0.32326498302850704,1.8561792863359443,2.0961515481728346,"['CYCS', 'HSPA1A']",0.7485226612371313,0,0,2
185,IL-9 signaling pathway WP22,0.32326498302850704,1.8561792863359443,2.0961515481728346,"['STAT3', 'JAK3']",0.7485226612371313,0,0,2
186,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.32326498302850704,1.8561792863359443,2.0961515481728346,"['ABCC3', 'HMOX1']",0.7485226612371313,0,0,2
187,Purine metabolism and related disorders WP4224,0.32326498302850704,1.8561792863359443,2.0961515481728346,"['GRM5', 'PAICS']",0.7485226612371313,0,0,2
188,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.3261062145119134,1.437595000844452,1.610871401734875,"['ADAMTSL2', 'STAT3', 'SPP1', 'SMAD6']",0.7510850578918006,0,0,4
189,Alzheimer's disease WP2059,0.34425845956151413,1.2857359176256815,1.3710606546135606,"['ATP5MD', 'VMP1', 'CYCS', 'CALM3', 'GRIN2B', 'CALM2']",0.7789538355799985,0,0,6
190,Mitochondrial complex I assembly model OXPHOS system WP4324,0.34580147950373435,1.3263745865318604,1.4084644763813856,"['NDUFA7', 'NDUFS6', 'NDUFAB1', 'NDUFB2', 'TMEM70']",0.7789538355799985,0,0,5
191,GDNF/RET signaling axis WP4830,0.34982721435003705,2.783246414602347,2.9232880176520832,['ROBO2'],0.7789538355799985,0,0,1
192,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.34982721435003705,2.783246414602347,2.9232880176520832,['STAT3'],0.7789538355799985,0,0,1
193,Thiamine metabolic pathways WP4297,0.34982721435003705,2.783246414602347,2.9232880176520832,['SLC25A19'],0.7789538355799985,0,0,1
194,Angiogenesis WP1539,0.3543970106449416,1.7131954207672224,1.7771618466722372,"['PDGFB', 'HIF1A']",0.7789538355799985,0,0,2
195,DNA Mismatch Repair WP531,0.3543970106449416,1.7131954207672224,1.7771618466722372,"['POLE4', 'RPA3']",0.7789538355799985,0,0,2
196,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3543970106449416,1.7131954207672224,1.7771618466722372,"['LDHA', 'HIF1A']",0.7789538355799985,0,0,2
197,Oxysterols derived from cholesterol WP4545,0.3543970106449416,1.7131954207672224,1.7771618466722372,"['CH25H', 'ACOT11']",0.7789538355799985,0,0,2
198,Oncostatin M Signaling Pathway WP2374,0.36265127005313147,1.2953762687067574,1.3139177600326002,"['CEBPB', 'PXN', 'STAT3', 'JAK3', 'HIF1A']",0.7930707067323531,0,0,5
199,7q11.23 copy number variation syndrome WP4932,0.36936690802988104,1.2186473390275954,1.21372985116062,"['GRIP1', 'SNAP25', 'ATP5MC3', 'DDX21', 'NRG1', 'ATP5F1E', 'ATP5MC1']",0.7996793558846924,0,0,7
200,G Protein Signaling Pathways WP35,0.36936690802988104,1.2186473390275954,1.21372985116062,"['GNG10', 'GNG3', 'ADCY9', 'PDE4D', 'PDE4B', 'PDE7B', 'CALM2']",0.7996793558846924,0,0,7
201,DNA damage response (only ATM dependent) WP710,0.38323701960273066,1.1997574042252097,1.150689283283821,"['CCND3', 'CDKN1A', 'WNT2B', 'WNT5B', 'BCL6', 'INSR', 'WNT5A']",0.8040598819150652,0,0,7
202,Regulation of Actin Cytoskeleton WP51,0.38327804278795563,1.1660538652449675,1.1182393518016152,"['CHRM3', 'FGF14', 'TMSB4X', 'PXN', 'PDGFB', 'FGF20', 'IQGAP1', 'CD14', 'ACTG1']",0.8040598819150652,0,0,9
203,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3850042069089358,1.5906378217083177,1.5182654196411023,"['BCL6', 'H2AFZ']",0.8040598819150652,0,0,2
204,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.3850042069089358,1.5906378217083177,1.5182654196411023,"['PTPN1', 'CEBPB']",0.8040598819150652,0,0,2
205,SARS coronavirus and innate immunity WP4912,0.3850042069089358,1.5906378217083177,1.5182654196411023,"['IFNAR2', 'IKBKE']",0.8040598819150652,0,0,2
206,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.3850042069089358,1.5906378217083177,1.5182654196411023,"['P4HA1', 'P3H2']",0.8040598819150652,0,0,2
207,Prion disease pathway WP3995,0.38710593247556874,1.3919934640522875,1.3210809963596082,"['HSPA5', 'STAT3', 'HSP90B1']",0.8040598819150652,0,0,3
208,Cell Differentiation - Index WP2029,0.40348419921279677,2.226336375488918,2.0206628601657415,['STAT3'],0.8040598819150652,0,0,1
209,Cellular Proteostasis WP4918,0.40348419921279677,2.226336375488918,2.0206628601657415,['PFDN5'],0.8040598819150652,0,0,1
210,Farnesoid X receptor pathway WP2879,0.40348419921279677,2.226336375488918,2.0206628601657415,['FKBP5'],0.8040598819150652,0,0,1
211,FOXP3 in COVID-19 WP5063,0.40348419921279677,2.226336375488918,2.0206628601657415,['STAT3'],0.8040598819150652,0,0,1
212,Glial Cell Differentiation WP2276,0.40348419921279677,2.226336375488918,2.0206628601657415,['GAP43'],0.8040598819150652,0,0,1
213,Glucuronidation WP698,0.40348419921279677,2.226336375488918,2.0206628601657415,['PGM5'],0.8040598819150652,0,0,1
214,Hedgehog Signaling Pathway Netpath WP47,0.40348419921279677,2.226336375488918,2.0206628601657415,['ARNTL'],0.8040598819150652,0,0,1
215,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.40348419921279677,2.226336375488918,2.0206628601657415,['LIPG'],0.8040598819150652,0,0,1
216,Selective expression of chemokine receptors during T-cell polarization WP4494,0.40348419921279677,2.226336375488918,2.0206628601657415,['IL4R'],0.8040598819150652,0,0,1
217,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4048153678001945,1.1933352080989876,1.0791619047660859,"['PDGFC', 'STAT3', 'GAB1', 'PDGFB', 'NRG1', 'IGF1']",0.8040598819150652,0,0,6
218,Hippo-Merlin Signaling Dysregulation WP4541,0.4048153678001945,1.1933352080989876,1.0791619047660859,"['PPP1R14A', 'CDH20', 'INSR', 'ITGAX', 'CDH12', 'CDH18']",0.8040598819150652,0,0,6
219,Nuclear receptors WP170,0.41496139104597424,1.4844212358572673,1.3056520846453248,"['ESRRA', 'RORA']",0.8204487777301682,0,0,2
220,Apoptosis WP254,0.42992019774987217,1.1845737709489417,0.9999646701911473,"['CASP4', 'CASP1', 'CYCS', 'IGF1', 'TNFRSF1B']",0.834157550878837,0,0,5
221,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.42992019774987217,1.1845737709489417,0.9999646701911473,"['NHSL1', 'TG', 'TBC1D4', 'MGLL', 'TSHR']",0.834157550878837,0,0,5
222,Aryl Hydrocarbon Receptor Netpath WP2586,0.43269834180479005,1.2846153846153847,1.0761408883228394,"['CDKN1A', 'HPGDS', 'HSP90AA1']",0.834157550878837,0,0,3
223,Hepatitis C and Hepatocellular Carcinoma WP3646,0.43269834180479005,1.2846153846153847,1.0761408883228394,"['CDKN1A', 'STAT3', 'HIF1A']",0.834157550878837,0,0,3
224,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.43269834180479005,1.2846153846153847,1.0761408883228394,"['IFNAR2', 'OAS1', 'IKBKE']",0.834157550878837,0,0,3
225,Synaptic Vesicle Pathway WP2267,0.4413645458420786,1.2036224706381775,0.9844236937118475,"['SNAP25', 'CACNA1B', 'CACNA1A', 'SYN3']",0.834157550878837,0,0,4
226,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.4413645458420786,1.2036224706381775,0.9844236937118475,"['EIF4A2', 'RPS6KA5', 'PIM1', 'MAP2K6']",0.834157550878837,0,0,4
227,Base Excision Repair WP4752,0.4441675500216184,1.391481723237598,1.1292617552857636,"['POLE4', 'APEX1']",0.834157550878837,0,0,2
228,PKC-gamma calcium signaling pathway in ataxia WP4760,0.4441675500216184,1.391481723237598,1.1292617552857636,"['CACNA1A', 'GRM1']",0.834157550878837,0,0,2
229,Purinergic signaling WP4900,0.4441675500216184,1.391481723237598,1.1292617552857636,"['P2RY12', 'P2RY13']",0.834157550878837,0,0,2
230,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.45271830128528107,1.8550630160799653,1.470109982335754,['SMAD6'],0.834157550878837,0,0,1
231,Cytokines and Inflammatory Response WP530,0.45271830128528107,1.8550630160799653,1.470109982335754,['IL15'],0.834157550878837,0,0,1
232,Differentiation of white and brown adipocyte WP2895,0.45271830128528107,1.8550630160799653,1.470109982335754,['CEBPB'],0.834157550878837,0,0,1
233,Estrogen Receptor Pathway WP2881,0.45271830128528107,1.8550630160799653,1.470109982335754,['STAT3'],0.834157550878837,0,0,1
234,LDLRAD4 and what we know about it WP4904,0.45271830128528107,1.8550630160799653,1.470109982335754,['PMEPA1'],0.834157550878837,0,0,1
235,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.45271830128528107,1.8550630160799653,1.470109982335754,['ANAPC11'],0.834157550878837,0,0,1
236,Senescence and Autophagy in Cancer WP615,0.4649296749598459,1.113254593175853,0.8526073172565917,"['GABARAPL1', 'CDKN1A', 'CEBPB', 'MAP1LC3A', 'PLAT', 'IGF1']",0.8490623449329168,0,0,6
237,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4725427117048117,1.309476270926125,0.9816189531702681,"['SCO2', 'NAMPT']",0.8490623449329168,0,0,2
238,Oxidative Stress WP408,0.4725427117048117,1.309476270926125,0.9816189531702681,"['MGST1', 'HMOX1']",0.8490623449329168,0,0,2
239,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.47698765525893017,1.192577030812325,0.8828226402426262,"['CDKN1A', 'HSP90AA1', 'MAP2K6']",0.8490623449329168,0,0,3
240,TGF-beta Receptor Signaling WP560,0.47698765525893017,1.192577030812325,0.8828226402426262,"['STAT3', 'SPP1', 'SMAD6']",0.8490623449329168,0,0,3
241,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.47869239896896876,1.141629748959592,0.8410352810316424,"['RPS6KA5', 'IRAK2', 'MAP3K8', 'MAP2K6']",0.8490623449329168,0,0,4
242,Ras signaling WP4223,0.4905693943491422,1.0500572509583312,0.7478387333643381,"['TIAM1', 'GNG10', 'GNG3', 'INSR', 'GAB1', 'CALM3', 'KSR2', 'GRIN2B', 'CALM2', 'RASGRP3']",0.8490623449329168,0,0,10
243,Apoptosis Modulation and Signaling WP1772,0.49562916966231785,1.0911520571531366,0.7659093886593596,"['CASP4', 'CASP1', 'CYCS', 'TNFRSF1B', 'HSPA1A']",0.8490623449329168,0,0,5
244,Interferon type I signaling pathways WP585,0.4969925238037143,1.1129581151832462,0.7781583840166749,"['IFNAR2', 'RPS6KA5', 'STAT3', 'MAP2K6']",0.8490623449329168,0,0,4
245,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.4978936568025424,1.5898677593592847,1.1087241163627375,['ELOB'],0.8490623449329168,0,0,1
246,ID signaling pathway WP53,0.4978936568025424,1.5898677593592847,1.1087241163627375,['ID2'],0.8490623449329168,0,0,1
247,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4978936568025424,1.5898677593592847,1.1087241163627375,['NRG3'],0.8490623449329168,0,0,1
248,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.4978936568025424,1.5898677593592847,1.1087241163627375,['ABCC3'],0.8490623449329168,0,0,1
249,RalA downstream regulated genes WP2290,0.4978936568025424,1.5898677593592847,1.1087241163627375,['YBX3'],0.8490623449329168,0,0,1
250,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.4978936568025424,1.5898677593592847,1.1087241163627375,['STAT3'],0.8490623449329168,0,0,1
251,Glycogen Synthesis and Degradation WP500,0.4985231879657076,1.15131845841785,0.8014387371897681,"['CALM3', 'PYGL', 'CALM2']",0.8490623449329168,0,0,3
252,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4985231879657076,1.15131845841785,0.8014387371897681,"['PXN', 'STAT3', 'GAB1']",0.8490623449329168,0,0,3
253,IL-7 signaling pathway WP205,0.500025168493981,1.236582535538149,0.8570714537643124,"['STAT3', 'JAK3']",0.8490623449329168,0,0,2
254,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.500025168493981,1.236582535538149,0.8570714537643124,"['HSPB1', 'LITAF']",0.8490623449329168,0,0,2
255,Physiological and pathological hypertrophy of the heart WP1528,0.500025168493981,1.236582535538149,0.8570714537643124,"['STAT3', 'CALM2']",0.8490623449329168,0,0,2
256,Wnt signaling WP428,0.511630191009077,1.0700423429781227,0.717092298249417,"['CCND3', 'WNT2B', 'WNT5B', 'WNT5A', 'ROR2']",0.8653745027614467,0,0,5
257,Hepatitis B infection WP4666,0.514928596758574,1.0324762642109124,0.6852824095541595,"['CDKN1A', 'TICAM2', 'STAT3', 'CYCS', 'IKBKE', 'JAK3', 'TLR4', 'MAP2K6', 'TLR2']",0.8675645229434341,0,0,9
258,DNA Replication WP466,0.5265690151727671,1.1713618249278548,0.7512796990344844,"['PRIM1', 'RPA3']",0.8783571024227889,0,0,2
259,TLR4 Signaling and Tolerance WP3851,0.5265690151727671,1.1713618249278548,0.7512796990344844,"['IKBKE', 'TLR4']",0.8783571024227889,0,0,2
260,Wnt signaling pathway and pluripotency WP399,0.5274199691222289,1.0497292217908454,0.6715728170041768,"['CCND3', 'WNT2B', 'WNT5B', 'LRRK2', 'WNT5A']",0.8783571024227889,0,0,5
261,Androgen receptor signaling pathway WP138,0.5375557478799848,1.0270139309509387,0.6374909704305701,"['CDKN1A', 'LIMK2', 'STAT3', 'DSTN', 'STUB1', 'CALR']",0.8812684930583804,0,0,6
262,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5393444588001635,1.3909713168187745,0.8587868622870585,['RYR2'],0.8812684930583804,0,0,1
263,Galanin receptor pathway WP4970,0.5393444588001635,1.3909713168187745,0.8587868622870585,['CDKN1A'],0.8812684930583804,0,0,1
264,Neuroinflammation WP4919,0.5393444588001635,1.3909713168187745,0.8587868622870585,['TLR4'],0.8812684930583804,0,0,1
265,Tryptophan catabolism leading to NAD+ production WP4210,0.5393444588001635,1.3909713168187745,0.8587868622870585,['NAMPT'],0.8812684930583804,0,0,1
266,Glycerophospholipid Biosynthetic Pathway WP2533,0.5521419674073086,1.11266318537859,0.660866386232862,"['PGS1', 'GK']",0.8834078486515953,0,0,2
267,Signal transduction through IL1R WP4496,0.5521419674073086,1.11266318537859,0.660866386232862,"['IRAK2', 'MAP2K6']",0.8834078486515953,0,0,2
268,G13 Signaling Pathway WP524,0.5602579117051555,1.043014705882353,0.6042789605518747,"['IQGAP1', 'IQGAP2', 'CALM2']",0.8834078486515953,0,0,3
269,PDGF Pathway WP2526,0.5602579117051555,1.043014705882353,0.6042789605518747,"['TIAM1', 'STAT3', 'PDGFB']",0.8834078486515953,0,0,3
270,Breast cancer pathway WP4262,0.5654172138990003,0.9961217534375367,0.567980045869552,"['CDKN1A', 'WNT2B', 'WNT5B', 'WNT5A', 'FGF20', 'IGF1']",0.8834078486515953,0,0,6
271,AGE/RAGE pathway WP2324,0.5671586015609162,1.0113041408852927,0.5735270562863918,"['INSR', 'STAT3', 'CYCS', 'HIF1A']",0.8834078486515953,0,0,4
272,AMP-activated protein kinase (AMPK) signaling WP1403,0.5671586015609162,1.0113041408852927,0.5735270562863918,"['CDKN1A', 'CPT1A', 'INSR', 'LEPR']",0.8834078486515953,0,0,4
273,Glycolysis in senescence WP5049,0.577377416093306,1.2362740837317108,0.6790348222608666,['LDHA'],0.8834078486515953,0,0,1
274,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.577377416093306,1.2362740837317108,0.6790348222608666,['MAP2K6'],0.8834078486515953,0,0,1
275,NAD+ metabolism WP3644,0.577377416093306,1.2362740837317108,0.6790348222608666,['NAMPT'],0.8834078486515953,0,0,1
276,Nanomaterial induced apoptosis WP2507,0.577377416093306,1.2362740837317108,0.6790348222608666,['CYCS'],0.8834078486515953,0,0,1
277,Omega-3/Omega-6 FA synthesis WP4723,0.577377416093306,1.2362740837317108,0.6790348222608666,['ACSL1'],0.8834078486515953,0,0,1
278,Osteopontin Signaling WP1434,0.577377416093306,1.2362740837317108,0.6790348222608666,['SPP1'],0.8834078486515953,0,0,1
279,Ovarian infertility WP34,0.577377416093306,1.2362740837317108,0.6790348222608666,['CEBPB'],0.8834078486515953,0,0,1
280,Riboflavin and CoQ disorders WP5037,0.577377416093306,1.2362740837317108,0.6790348222608666,['RFK'],0.8834078486515953,0,0,1
281,Serotonin and anxiety WP3947,0.577377416093306,1.2362740837317108,0.6790348222608666,['GRM1'],0.8834078486515953,0,0,1
282,Urea cycle and metabolism of amino groups WP497,0.577377416093306,1.2362740837317108,0.6790348222608666,['ARG2'],0.8834078486515953,0,0,1
283,Vitamin A and carotenoid metabolism WP716,0.577377416093306,1.2362740837317108,0.6790348222608666,['BCO2'],0.8834078486515953,0,0,1
284,Splicing factor NOVA regulated synaptic proteins WP4148,0.5797888999333328,1.0112893642305407,0.5512449405037854,"['EPB41L3', 'KCNMA1', 'GRIN2B']",0.8839220947154879,0,0,3
285,MET in type 1 papillary renal cell carcinoma WP4205,0.5838376884263962,0.9887143688190808,0.5320591032848763,"['CDKN1A', 'STAT3', 'GAB1', 'JAK3']",0.8839220947154879,0,0,4
286,Metapathway biotransformation Phase I and II WP702,0.5838376884263962,0.9887143688190808,0.5320591032848763,"['NDST3', 'MGST1', 'HS3ST4', 'GAL3ST4']",0.8839220947154879,0,0,4
287,Parkinson's disease pathway WP2371,0.6003028028650195,1.0112746261571326,0.5160747590210054,"['LRRK2', 'CYCS']",0.8956575905516501,0,0,2
288,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.6003028028650195,1.0112746261571326,0.5160747590210054,"['CALM3', 'CALM2']",0.8956575905516501,0,0,2
289,Vitamin D-sensitive calcium signaling in depression WP4698,0.6003028028650195,1.0112746261571326,0.5160747590210054,"['GRM5', 'GRIN2B']",0.8956575905516501,0,0,2
290,7-oxo-C and 7beta-HC pathways WP5064,0.6122740110930448,1.11251629726206,0.5457730898516255,['ACOT11'],0.8956575905516501,0,0,1
291,Cancer immunotherapy by PD-1 blockade WP4585,0.6122740110930448,1.11251629726206,0.5457730898516255,['STAT3'],0.8956575905516501,0,0,1
292,FOXA2 pathway WP5066,0.6122740110930448,1.11251629726206,0.5457730898516255,['ABCC3'],0.8956575905516501,0,0,1
293,Globo Sphingolipid Metabolism WP1424,0.6122740110930448,1.11251629726206,0.5457730898516255,['ST6GALNAC5'],0.8956575905516501,0,0,1
294,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6122740110930448,1.11251629726206,0.5457730898516255,['UGCG'],0.8956575905516501,0,0,1
295,Omega-9 FA synthesis WP4724,0.6122740110930448,1.11251629726206,0.5457730898516255,['ACSL1'],0.8956575905516501,0,0,1
296,TP53 network WP1742,0.6122740110930448,1.11251629726206,0.5457730898516255,['CDKN1A'],0.8956575905516501,0,0,1
297,Exercise-induced Circadian Regulation WP410,0.6171669404619851,0.9532773109243697,0.4600666192642097,"['CEBPB', 'ERC2', 'ARNTL']",0.8967559906712735,0,0,3
298,Regulation of Microtubule Cytoskeleton WP2038,0.6171669404619851,0.9532773109243697,0.4600666192642097,"['TIAM1', 'STMN1', 'STAT3']",0.8967559906712735,0,0,3
299,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6349905971022691,0.9266884531590414,0.4208510090269877,"['RYR2', 'CACNA2D3', 'ACTG1']",0.9080854231118533,0,0,3
300,Canonical and non-canonical Notch signaling WP3845,0.644292572070484,1.0112599265141637,0.4445522417598425,['RBPJ'],0.9080854231118533,0,0,1
301,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.644292572070484,1.0112599265141637,0.4445522417598425,['RAB27A'],0.9080854231118533,0,0,1
302,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.644292572070484,1.0112599265141637,0.4445522417598425,['WNT5A'],0.9080854231118533,0,0,1
303,Imatinib and Chronic Myeloid Leukemia WP3640,0.644292572070484,1.0112599265141637,0.4445522417598425,['PIM1'],0.9080854231118533,0,0,1
304,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.644292572070484,1.0112599265141637,0.4445522417598425,['OAS1'],0.9080854231118533,0,0,1
305,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.644292572070484,1.0112599265141637,0.4445522417598425,['ZBTB16'],0.9080854231118533,0,0,1
306,Hematopoietic Stem Cell Differentiation WP2849,0.6444539277613355,0.9267841601392516,0.40718442279666267,"['PIM1', 'RUNX1']",0.9080854231118533,0,0,2
307,Neural Crest Cell Migration during Development WP4564,0.6444539277613355,0.9267841601392516,0.40718442279666267,"['TIAM1', 'STAT3']",0.9080854231118533,0,0,2
308,Non-small cell lung cancer WP4255,0.6466632306498723,0.9075755956832995,0.3956390927474596,"['CDKN1A', 'STAT3', 'CYCS', 'JAK3']",0.9080854231118533,0,0,4
309,Cytosolic DNA-sensing pathway WP4655,0.6522276364614004,0.9015368309485956,0.38528226067909904,"['CASP1', 'IKBKE', 'POLR2K']",0.9080854231118533,0,0,3
310,DNA damage response WP707,0.6522276364614004,0.9015368309485956,0.38528226067909904,"['CDKN1A', 'CCND3', 'CYCS']",0.9080854231118533,0,0,3
311,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6522276364614004,0.9015368309485956,0.38528226067909904,"['STMN1', 'PXN', 'STAT3']",0.9080854231118533,0,0,3
312,Osteoblast differentiation WP4787,0.6613505389437546,0.8893193717277487,0.3677080043685282,"['WNT2B', 'WNT5B', 'WNT5A', 'RBPJ']",0.9172831630173532,0,0,4
313,miRNA regulation of DNA damage response WP1530,0.6688747076728713,0.8777089783281734,0.35297814318306103,"['CDKN1A', 'CCND3', 'CYCS']",0.9172831630173532,0,0,3
314,Ebstein-Barr virus LMP1 signaling WP262,0.6736701753325378,0.9268796175575836,0.3661310202590136,['HSP90AA1'],0.9172831630173532,0,0,1
315,NAD+ biosynthetic pathways WP3645,0.6736701753325378,0.9268796175575836,0.3661310202590136,['NAMPT'],0.9172831630173532,0,0,1
316,Sleep regulation WP3591,0.6736701753325378,0.9268796175575836,0.3661310202590136,['PER3'],0.9172831630173532,0,0,1
317,Focal Adhesion WP306,0.6764203779801609,0.8887368421052632,0.3474432567909327,"['FGR', 'CCND3', 'PDGFC', 'PXN', 'PDGFB', 'SPP1', 'IGF1', 'ACTG1']",0.9172831630173532,0,0,8
318,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6846574236437145,0.8552922273548905,0.32401606552000456,"['MAP1LC3A', 'IGF1']",0.9172831630173532,0,0,2
319,Prader-Willi and Angelman Syndrome WP3998,0.6846574236437145,0.8552922273548905,0.32401606552000456,"['PCSK1', 'GABRG3']",0.9172831630173532,0,0,2
320,Cell cycle WP179,0.695483694019599,0.8547232583929831,0.31039079642125883,"['ANAPC13', 'CCND3', 'CDKN1A', 'ANAPC11', 'YWHAH']",0.9172831630173532,0,0,5
321,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7003991329025319,0.8336274509803921,0.29685883388553974,"['CDKN1A', 'TMSB4X', 'PFN2']",0.9172831630173532,0,0,3
322,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7003991329025319,0.8336274509803921,0.29685883388553974,"['IFI27L2', 'TLR4', 'TLR2']",0.9172831630173532,0,0,3
323,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.7006243917934303,0.8554808945943235,0.30436586131797033,['MAP2K6'],0.9172831630173532,0,0,1
324,Endothelin Pathways WP2197,0.7006243917934303,0.8554808945943235,0.30436586131797033,['CALM2'],0.9172831630173532,0,0,1
325,Heart Development WP1591,0.7006243917934303,0.8554808945943235,0.30436586131797033,['BHLHE40'],0.9172831630173532,0,0,1
326,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7006243917934303,0.8554808945943235,0.30436586131797033,['RAB27A'],0.9172831630173532,0,0,1
327,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.7006243917934303,0.8554808945943235,0.30436586131797033,['PXN'],0.9172831630173532,0,0,1
328,Mitochondrial Gene Expression WP391,0.7006243917934303,0.8554808945943235,0.30436586131797033,['ESRRA'],0.9172831630173532,0,0,1
329,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.7006243917934303,0.8554808945943235,0.30436586131797033,['RPS6KA5'],0.9172831630173532,0,0,1
330,Triacylglyceride synthesis WP325,0.7006243917934303,0.8554808945943235,0.30436586131797033,['GK'],0.9172831630173532,0,0,1
331,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7033210395421738,0.8235180350062856,0.2898304365838416,"['STAT3', 'GABRG3']",0.9172831630173532,0,0,2
332,Neural Crest Cell Migration in Cancer WP4565,0.7033210395421738,0.8235180350062856,0.2898304365838416,"['TIAM1', 'STAT3']",0.9172831630173532,0,0,2
333,Thermogenesis WP4321,0.7074479209617094,0.8416736169029747,0.2912958843689105,"['CPT1A', 'ADCY9', 'ACSL1', 'MGLL', 'ACTG1']",0.9198947440733337,0,0,5
334,Gastric Cancer Network 2 WP2363,0.7253548893599701,0.7942819891972435,0.2550393727228038,['RNF144B'],0.93475793777639,0,0,1
335,Overview of interferons-mediated signaling pathway WP4558,0.7253548893599701,0.7942819891972435,0.2550393727228038,['IFNAR2'],0.93475793777639,0,0,1
336,Sphingolipid Metabolism (general overview) WP4725,0.7253548893599701,0.7942819891972435,0.2550393727228038,['UGCG'],0.93475793777639,0,0,1
337,Pathways Regulating Hippo Signaling WP4540,0.7284570516437653,0.807996192289386,0.2559946941637545,"['CDH20', 'INSR', 'CDH12', 'CDH18']",0.935970039649111,0,0,4
338,Amyotrophic lateral sclerosis (ALS) WP2447,0.7378882604699399,0.7665436211398218,0.2330008024518288,"['CASP1', 'MAP2K6']",0.9424944447890382,0,0,2
339,Integrated Cancer Pathway WP1971,0.7378882604699399,0.7665436211398218,0.2330008024518288,"['CDKN1A', 'BACH1']",0.9424944447890382,0,0,2
340,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7480449047681105,0.7412429378531074,0.21517709482634562,['CDKN1A'],0.9470860928789235,0,0,1
341,Prostaglandin Synthesis and Regulation WP98,0.7480449047681105,0.7412429378531074,0.21517709482634562,['HPGDS'],0.9470860928789235,0,0,1
342,Sphingolipid Metabolism (integrated pathway) WP4726,0.7480449047681105,0.7412429378531074,0.21517709482634562,['UGCG'],0.9470860928789235,0,0,1
343,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7538459110416506,0.7409051348999129,0.209355558985033,"['IFNAR2', 'CXCL12']",0.9486012167786884,0,0,2
344,Fragile X Syndrome  WP4549,0.756289110234557,0.8093654183092422,0.22608130082852745,"['GRIP1', 'CPT1A', 'GRM5', 'GAB1', 'GRIN2B', 'GRM1', 'HCN1']",0.9486012167786884,0,0,7
345,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.768862594016659,0.6948337679269883,0.18263219680524545,['SGK1'],0.9486012167786884,0,0,1
346,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.768862594016659,0.6948337679269883,0.18263219680524545,['MAP1LC3A'],0.9486012167786884,0,0,1
347,MTHFR deficiency WP4288,0.768862594016659,0.6948337679269883,0.18263219680524545,['CYCS'],0.9486012167786884,0,0,1
348,Vitamin D in inflammatory diseases WP4482,0.768862594016659,0.6948337679269883,0.18263219680524545,['MAP2K6'],0.9486012167786884,0,0,1
349,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.76895849212314,0.7169207445464499,0.18834819018448765,"['CH25H', 'ACSL1']",0.9486012167786884,0,0,2
350,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.76895849212314,0.7169207445464499,0.18834819018448765,"['ADCY9', 'BANF1']",0.9486012167786884,0,0,2
351,IL-2 signaling pathway WP49,0.76895849212314,0.7169207445464499,0.18834819018448765,"['STAT3', 'JAK3']",0.9486012167786884,0,0,2
352,Eukaryotic Transcription Initiation WP405,0.7832566403171697,0.6944353785900783,0.1696470014271818,"['POLR2I', 'POLR2K']",0.96074171968033,0,0,2
353,Nucleotide Excision Repair WP4753,0.7832566403171697,0.6944353785900783,0.1696470014271818,"['POLE4', 'RPA3']",0.96074171968033,0,0,2
354,16p11.2 distal deletion syndrome WP4950,0.7879622718239444,0.6538845003451185,0.15582399075468686,['INSR'],0.96074171968033,0,0,1
355,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7879622718239444,0.6538845003451185,0.15582399075468686,['WNT5A'],0.96074171968033,0,0,1
356,Ebola Virus Pathway on Host WP4217,0.7898938850027656,0.7653181283374061,0.1805053816620422,"['TIAM1', 'SCIN', 'IQGAP1', 'IKBKE', 'TLR4', 'ACTG1']",0.96074171968033,0,0,6
357,Kit receptor signaling pathway WP304,0.7927579470140829,0.7088861076345432,0.1646298247076408,"['STAT3', 'SOCS6', 'SH2B2']",0.961524344697753,0,0,3
358,IL-6 signaling pathway WP364,0.7967716931546822,0.6733127620856081,0.15296797313930974,"['STAT3', 'GAB1']",0.9636931372513335,0,0,2
359,Melanoma WP4685,0.8038021655309603,0.6940359477124183,0.15157891043667424,"['CDKN1A', 'CALM3', 'CALM2']",0.9640756413839455,0,0,3
360,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8054855499110418,0.6174851513834565,0.13356822285490808,['CALM2'],0.9640756413839455,0,0,1
361,Alpha 6 Beta 4 signaling pathway WP244,0.8215623810782953,0.5849173128388115,0.1149639822057552,['GAB1'],0.9640756413839455,0,0,1
362,EPO Receptor Signaling WP581,0.8215623810782953,0.5849173128388115,0.1149639822057552,['STAT3'],0.9640756413839455,0,0,1
363,Fatty Acid Biosynthesis WP357,0.8215623810782953,0.5849173128388115,0.1149639822057552,['ACSL1'],0.9640756413839455,0,0,1
364,Intraflagellar transport proteins binding to dynein WP4532,0.8215623810782953,0.5849173128388115,0.1149639822057552,['DYNLL1'],0.9640756413839455,0,0,1
365,miRNAs involvement in the immune response in sepsis WP4329,0.8215623810782953,0.5849173128388115,0.1149639822057552,['TLR4'],0.9640756413839455,0,0,1
366,Nanoparticle-mediated activation of receptor signaling WP2643,0.8215623810782953,0.5849173128388115,0.1149639822057552,['PXN'],0.9640756413839455,0,0,1
367,Proximal tubule transport WP4917,0.8215623810782953,0.5849173128388115,0.1149639822057552,['CA2'],0.9640756413839455,0,0,1
368,Type II interferon signaling (IFNG) WP619,0.8215623810782953,0.5849173128388115,0.1149639822057552,['OAS1'],0.9640756413839455,0,0,1
369,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8215794726805448,0.6346885490488624,0.12473318593304683,"['CDKN1A', 'TLR4']",0.9640756413839455,0,0,2
370,Amino Acid metabolism WP3925,0.8244085661326206,0.6661176470588235,0.12862001651261593,"['ARG2', 'LDHA', 'IARS']",0.9647808355011479,0,0,3
371,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8329357024147575,0.6169857847403539,0.11278427820247588,"['GRIN2B', 'GRM1']",0.971053858948246,0,0,2
372,Sphingolipid pathway WP1422,0.8363120182550041,0.5556062581486311,0.09931656768402256,['UGCG'],0.971053858948246,0,0,1
373,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8364967422348631,0.7154347642028618,0.1277284665601133,"['PTPN1', 'RPS6KA5', 'INSR', 'FLOT2', 'MAP3K8', 'MAP2K6']",0.971053858948246,0,0,6
374,ErbB signaling pathway WP673,0.8401976832494101,0.6724575598921149,0.11708701761654845,"['CDKN1A', 'NRG3', 'GAB1', 'NRG1']",0.9727422375588091,0,0,4
375,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8436354156817836,0.6002399266106838,0.10206170567754615,"['MAP3K8', 'CALM2']",0.9741176933072329,0,0,2
376,SARS-CoV-2 mitochondrial interactions WP5038,0.8498438943268988,0.529086732476563,0.0860837870508934,['IKBKE'],0.9753461950323501,0,0,1
377,Head and Neck Squamous Cell Carcinoma WP4674,0.8518361033832276,0.6281908990011099,0.10073740718047022,"['CDKN1A', 'DDIT4', 'GAB1']",0.9753461950323501,0,0,3
378,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8537094871068376,0.5843754294352068,0.09242734364815679,"['CXCL12', 'IKBKE']",0.9753461950323501,0,0,2
379,Rett syndrome causing genes WP4312,0.8537094871068376,0.5843754294352068,0.09242734364815679,"['IMPDH2', 'GRIN2B']",0.9753461950323501,0,0,2
380,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8622584296702196,0.504978072774683,0.07483787705822884,['VMP1'],0.9809986305709907,0,0,1
381,p53 transcriptional gene network WP4963,0.8631881714723959,0.5693244962174466,0.08376048204866389,"['CDKN1A', 'DRAM1']",0.9809986305709907,0,0,2
382,Prolactin Signaling Pathway WP2037,0.8679781503355455,0.605204991087344,0.08569021035234443,"['PTPN1', 'PXN', 'STAT3']",0.9838600499876733,0,0,3
383,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8703595912137874,0.6924277266754271,0.09614277935792744,"['GRIP1', 'TIAM1', 'RPS6KA5', 'STAT3', 'SPP1', 'GRIN2B', 'SH2B2']",0.9839835587351695,0,0,7
384,GABA receptor Signaling WP4159,0.8736477736378813,0.4829658182642707,0.06523805175053779,['GABRG3'],0.9845072781122355,0,0,1
385,IL-3 signaling pathway WP286,0.880476674443819,0.5414252053747691,0.06891901205405436,"['IL3RA', 'STAT3']",0.9845072781122355,0,0,2
386,Translation Factors WP107,0.880476674443819,0.5414252053747691,0.06891901205405436,"['EIF4A2', 'EEF1B2']",0.9845072781122355,0,0,2
387,BDNF-TrkB Signaling WP3676,0.8840964849829372,0.4627879182963929,0.05701041622038991,['GAB1'],0.9845072781122355,0,0,1
388,miRNA regulation of prostate cancer signaling pathways WP3981,0.8840964849829372,0.4627879182963929,0.05701041622038991,['CDKN1A'],0.9845072781122355,0,0,1
389,Integrated breast cancer pathway WP1984,0.8852830008353411,0.658142979652296,0.08019334664140033,"['PLK3', 'ITPKC', 'FAU', 'SMAD6', 'BACH1', 'RASGRP3']",0.9845072781122355,0,0,6
390,Modulators of TCR signaling and T cell activation WP5072,0.8883430401625546,0.5284719631978118,0.06256965573386342,"['ELOB', 'MAP3K8']",0.9845072781122355,0,0,2
391,ATM Signaling Pathway WP2516,0.893682156412816,0.44422425032594526,0.049933069842751705,['CDKN1A'],0.9845072781122355,0,0,1
392,PDGFR-beta pathway WP3972,0.893682156412816,0.44422425032594526,0.049933069842751705,['STAT3'],0.9845072781122355,0,0,1
393,Integrin-mediated Cell Adhesion WP185,0.8956708035305205,0.5639082751744766,0.06213273346851456,"['PXN', 'ITGAX', 'MAP2K6']",0.9845072781122355,0,0,3
394,Glioblastoma signaling pathways WP2261,0.9017247603689647,0.5544444444444444,0.0573550318344699,"['CDKN1A', 'GAB1', 'MAP2K6']",0.9845072781122355,0,0,3
395,Leptin signaling pathway WP2034,0.9017247603689647,0.5544444444444444,0.0573550318344699,"['PTPN1', 'STAT3', 'LEPR']",0.9845072781122355,0,0,3
396,MAPK Cascade WP422,0.9024759875351356,0.4270885568147628,0.04382492167803466,['MAP2K6'],0.9845072781122355,0,0,1
397,Small cell lung cancer WP4658,0.9026544790082159,0.5043318300498457,0.05165136403452392,"['CDKN1A', 'CYCS']",0.9845072781122355,0,0,2
398,IL-1 signaling pathway WP195,0.9091504348987782,0.4930664345807949,0.04696196639668136,"['IRAK2', 'MAP2K6']",0.9887308085511504,0,0,2
399,Pancreatic adenocarcinoma pathway WP4263,0.9128904670824566,0.5364326375711574,0.04889013581190971,"['TIAM1', 'CDKN1A', 'STAT3']",0.9887308085511504,0,0,3
400,B Cell Receptor Signaling Pathway WP23,0.9153537717063154,0.5681970734326756,0.05025399281715245,"['BCL6', 'GAB1', 'RASGRP3', 'MAP2K6']",0.9887308085511504,0,0,4
401,Notch Signaling WP268,0.9179440762992204,0.39648910411622273,0.033946924987447606,['RBPJ'],0.9887308085511504,0,0,1
402,Target Of Rapamycin (TOR) Signaling WP1471,0.9179440762992204,0.39648910411622273,0.033946924987447606,['DDIT4'],0.9887308085511504,0,0,1
403,EGF/EGFR signaling pathway WP437,0.9234668697919648,0.6245284218557925,0.04972517440751304,"['PLSCR1', 'RPS6KA5', 'LIMK2', 'STMN1', 'STAT3', 'GAB1', 'IQGAP1']",0.9900860056335355,0,0,7
404,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9247332907770485,0.3827721080789462,0.029951885817663622,['SUPT4H1'],0.9900860056335355,0,0,1
405,Mesodermal commitment pathway WP2857,0.9274873254219868,0.5114932126696833,0.03850323975340768,"['BHLHE40', 'RPL38', 'SMAD6']",0.9900860056335355,0,0,3
406,DNA Repair Pathways Full Network WP4946,0.9283485410790194,0.5469588261909378,0.04066531321497804,"['POLE4', 'CENPX', 'RPA3', 'APEX1']",0.9900860056335355,0,0,4
407,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9309614286472165,0.36996957844415473,0.0264666737774815,['STAT3'],0.9904331661037955,0,0,1
408,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9359601363700341,0.44349869451697127,0.029351804788959133,"['CDKN1A', 'CYCS']",0.991638605528006,0,0,2
409,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9366748029121349,0.35799301846322074,0.02341958786782359,['ACTG1'],0.991638605528006,0,0,1
410,Interleukin-11 Signaling Pathway WP2332,0.9467237361150735,0.33621745486152266,0.018407217646323193,['STAT3'],0.9947851419099693,0,0,1
411,Male infertility WP4673,0.9482465782825095,0.4182472042957781,0.022225952084635514,"['INSR', 'ARNTL']",0.9947851419099693,0,0,2
412,Copper homeostasis WP3286,0.9511340617799706,0.3262903596901603,0.016347230908933717,['SCO2'],0.9947851419099693,0,0,1
413,Neural Crest Differentiation WP2064,0.9511340617799706,0.3262903596901603,0.016347230908933717,['RBPJ'],0.9947851419099693,0,0,1
414,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9511340617799706,0.3262903596901603,0.016347230908933717,['MAP1LC3A'],0.9947851419099693,0,0,1
415,IL-5 signaling pathway WP127,0.9551797106186138,0.3169305271000186,0.014533095748410945,['STAT3'],0.9963289924770095,0,0,1
416,ATM Signaling Network in Development and Disease  WP3878,0.9588908005194486,0.30809068520932925,0.012933055016171677,['HSPB1'],0.9963289924770095,0,0,1
417,TGF-beta Signaling Pathway WP366,0.9641721196943612,0.47570793221865676,0.017356419359159853,"['EID2', 'CDKN1A', 'LIMK2', 'MAP2K6']",0.9963289924770095,0,0,4
418,Wnt Signaling Pathway WP363,0.9654175575545916,0.2918067659370068,0.010270013388379304,['ROR2'],0.9963289924770095,0,0,1
419,Corticotropin-releasing hormone signaling pathway WP2355,0.9664109063999923,0.3754480683276541,0.012827621127951331,"['HSP90AA1', 'TLR4']",0.9963289924770095,0,0,2
420,Gastrin signaling pathway WP4659,0.9702309581567624,0.42015388433854556,0.01269752710549251,"['CDKN1A', 'PXN', 'STAT3']",0.9963289924770095,0,0,3
421,Energy Metabolism WP1541,0.9709091557665155,0.27715123859191654,0.00818216209501454,['ESRRA'],0.9963289924770095,0,0,1
422,T-cell receptor (TCR) signaling pathway WP69,0.9730156343765919,0.35715488924450434,0.009770017963522486,"['MAP3K8', 'OPRM1']",0.9963289924770095,0,0,2
423,RANKL/RANK signaling pathway WP2018,0.9733190850295035,0.27035965274906987,0.007311420215317543,['MAP2K6'],0.9963289924770095,0,0,1
424,Endometrial cancer WP4155,0.9775571622102787,0.2577241442042388,0.005849954288141758,['CDKN1A'],0.9983071963137986,0,0,1
425,Ciliary landscape WP4352,0.9866329098749648,0.48502880189092473,0.006527146026542834,"['DOCK5', 'TBC1D4', 'IQGAP1', 'IQGAP2', 'DYNLL1', 'COX6C', 'CALM2']",0.9997282180509327,0,0,7
426,22q11.2 copy number variation syndrome WP4657,0.9866458100340068,0.22600643908149962,0.0030384665098572823,['ARNTL'],0.9997282180509327,0,0,1
427,DNA IR-damage and cellular response via ATR WP4016,0.9896999731472822,0.21289238792498244,0.0022041683970088375,['BCL6'],0.9997282180509327,0,0,1
428,Proteasome Degradation WP183,0.9927151732078575,0.19759266157571242,0.0014446969107535942,['H2AFZ'],0.9997282180509327,0,0,1
429,16p11.2 proximal deletion syndrome WP4949,0.9943821120315904,0.18747928314144918,0.0010562072217222653,['MAP2K6'],0.9997282180509327,0,0,1
430,Genes related to primary cilium development (based on CRISPR) WP4536,0.9963571073538907,0.17273060625814862,0.0006303879715605056,['DYNLL1'],0.9997282180509327,0,0,1
431,Endoderm differentiation WP2853,0.9984685275219372,0.1492124458226153,0.00022868991504908803,['NME1'],0.9997282180509327,0,0,1
432,mRNA Processing WP411,0.9992555354307259,0.20202649292164707,0.00015045757815449916,"['SNRPD1', 'SNRPE']",0.9997282180509327,0,0,2
433,Ciliopathies WP4803,0.9997282180509327,0.11718771671891037,3.1853834901380366e-05,['CCDC65'],0.9997282180509327,0,0,1
